XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.21.2

Stock-Based Compensation | 9 Months Ended
--- | ---
Jun. 30, 2021
Share Based Compensation [Abstract] |
Stock-Based Compensation | Note 9: Stock-Based Compensation Our 2014 Omnibus Equity Incentive Plan (the “2014 Plan”) authorizes the issuance of distribution equivalent rights, incentive stock options, non-qualified stock options, performance stock, performance units, restricted ordinary shares, restricted stock units, stock appreciation rights, tandem stock appreciation rights and unrestricted ordinary shares to our directors, officer, employees, consultants and advisors. The Company has reserved up to 300,000 shares of common stock for issuance under the 2014 Plan. From time to time, the Company grants stock options to directors, officers, and employees. These awards are valued at the grant date by determining the fair value of the instruments, net of estimated forfeitures. The value of each award is amortized on a straight-line basis over the requisite service period. The following table summarizes stock option activity for the twelve months ended September 30, 2020 and the nine months ended June 30, 2021:
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life |  |  | Intrinsic Value |
Outstanding at September 30, 2019 |  |  | 200,418 |  |  | $ | 16.37 |  |  |  | 2.40 |  |  | $ | 27 |
Forfeited |  |  | (81,250 | ) |  |  |  |  |  |  |  |  |
Outstanding at September 30, 2020 |  |  | 119,168 |  |  | $ | 19.07 |  |  |  | 2.71 |  |  | $ | — |
Exercisable at September 30, 2020 |  |  | 95,001 |  |  | $ | 15.50 |  |  |  | 1.55 |  |  | $ | — |
Outstanding at September 30, 2020 |  |  | 119,168 |  |  | $ | 19.07 |  |  |  | 2.71 |  |  | $ | — |
Granted |  |  | 2,500 |  |  | $ | 42.75 |  |  |  |  |  |  |
Exercised |  |  | (16,668 | ) |  | $ | 10.86 |  |  |  |  |  |  |
Outstanding at June 30, 2021 |  |  | 105,000 |  |  | $ | 20.93 |  |  |  | 2.95 |  |  | $ | 1,290 |
Exercisable at June 30, 2021 |  |  | 90,500 |  |  | $ | 17.78 |  |  |  | 2.20 |  |  | $ | 1,290 |
The Company recognized compensation expense of $(57) and $19 during the three months ended June 30, 2021 and 2020, respectively, and $230 and $67 during the nine months ended June 30, 2021 and 2020, respectively, related to stock option awards granted to certain employees and officers based on the grant date fair value of the awards, net of estimated forfeitures and the revaluation for existing options whereby the expiration date was extended. At June 30, 2021, the Company had $69 of unrecognized compensation expense (net of estimated forfeitures) associated with stock option awards which the Company expects to recognize as compensation expense through December 2021. The exercise price for stock options outstanding and exercisable outstanding at June 30, 2021 is as follows:
Outstanding |  |  | Exercisable |
Number of Options |  |  | Exercise Price ($) |  |  | Number of Options |  |  | Exercise Price ($) |
| 25,000 |  |  |  | 10.00 |  |  |  | 25,000 |  |  |  | 10.00 |
| 6,250 |  |  |  | 12.50 |  |  |  | 6,250 |  |  |  | 12.50 |
| 6,250 |  |  |  | 15.00 |  |  |  | 6,250 |  |  |  | 15.00 |
| 25,000 |  |  |  | 15.18 |  |  |  | 25,000 |  |  |  | 15.18 |
| 8,000 |  |  |  | 23.41 |  |  |  | 8,000 |  |  |  | 23.41 |
| 1,250 |  |  |  | 23.89 |  |  |  | — |  |  |  | — |
| 8,000 |  |  |  | 27.60 |  |  |  | 8,000 |  |  |  | 27.60 |
| 8,000 |  |  |  | 31.74 |  |  |  | 8,000 |  |  |  | 31.74 |
| 8,000 |  |  |  | 36.50 |  |  |  | 4,000 |  |  |  | 36.50 |
| 8,000 |  |  |  | 41.98 |  |  |  | — |  |  |  | — |
| 1,250 |  |  |  | 61.60 |  |  |  | — |  |  |  | — |
| 105,000 |  |  |  |  |  |  | 90,500 |  |  |  |
The following table summarizes information about the Company’s non-vested shares outstanding as of June 30, 2021:
Non-vested Shares |  | Number of Shares |  |  | Average Grant-Date Fair Value |
Non-vested at September 30, 2020 |  |  | 24,167 |  |  | $ | 33.10 |
Granted |  |  | 2,500 |  |  | $ | 23.89 |
Vested |  |  | (12,167 | ) |  | $ | 39.78 |
Non-vested at June 30, 2021 |  |  | 14,500 |  |  | $ | 40.60 |
The following table depicts the Black-Scholes model valuation assumptions for the stock options granted during the nine months ended June 30, 2021. There were no stock option grants during the nine months ended June 30, 2020.
Risk-free interest rate |  | 1.10%
Expected life of the options |  | 6 years
Expected volatility |  | 97%
Expected dividend yield |  | 0%

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration